In the last trial , on 72 patients on phenprocoumon with an INR of 7.0-11 .0 , the INR decreased slightly more in the solution group ( 4.7 , 95 % CI 4.3-5 .1 ) than in the tablet group ( 4.2 , 95 % CI 3.8-4 .6 ) .